Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 5, 2008, Pages

  Müller, Ulrich R ^a   Jutel, Marek ^b,c   Reimers, Andrea ^a   Zumkehr, Judith ^b   Huber, Clarissa ^a   Kriegel, Carola ^a   Steiner, Urs ^a   Haeberli, Gabrielle ^a   Akdis, Mübeccel ^b   Helbling, Arthur ^a   Schnyder, Benno ^d   Blaser, Kurt ^b   Akdis, Cezmi ^b  

^a Spital Ziegler   (Switzerland)

^b SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

antihistamine preventive medication; cytokines; histamine receptors; T cells; Venom immunotherapy

Indexed keywords

ANTIHISTAMINIC AGENT; BEE VENOM; GAMMA INTERFERON; HISTAMINE RECEPTOR; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 13; LEVOCETIRIZINE; PHOSPHOLIPASE A2; PLACEBO;

ADULT; AGED; ALLERGY; ANXIETY DISORDER; ARTICLE; BEE STING; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; HEADACHE; HEAT SENSATION; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; IMMUNOTHERAPY; LYMPHOCYTE CULTURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; PRURITUS; REAL TIME POLYMERASE CHAIN REACTION; SIDE EFFECT; SKIN TEST; T LYMPHOCYTE ACTIVATION; UNEASINESS;

EID: 55649095720     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.08.007     Document Type: Article

References (34)

1. Bilo B.M., Ruëff F., Mosbech H., Bonifazi F., Oude-Elberink J.N.G., Birnbaum J., et al. Diagnosis of Hymenoptera venom allergy. Allergy 60 (2005) 1339-1349
2. Bonifazi F., Jutel M., Bilo B.M., Birnbaum J., Müller U., and Bucher C. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy 60 (2005) 1459-1470
3. Berchtold E., Maibach R., and Müller U. Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine. Clin Exp Allergy 22 (1992) 59-65
4. Brockow K., Kiehn M., Riethmüller C., Vieluf D., Berger J., and Ring J. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 100 (1997) 458-463
5. Reimers A.R., Hari Y., and Müller U. Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial. Allergy 55 (2000) 484-488
6. Jarisch R., Götz M., Aberer W., Sidl R., Stabel A., and Zajc J. Reduction of side effects of specific immunotherapy by premedication with antihistaminics and reduction of maximal dosage to 50,000 SQ-U/ml. In: Kurth R. (Ed) (1988), Gustav Fischer Verlag, Bundesamt für Sera und Impfstoffe zu Frankfurt a.M, Stuttgart 163-175
7. Nielsen L., Johnson C.R., Mosbech H., Poulsen L.K., and Malling H.J. Antihistamine premedication in specific cluster immunotherapy: A double-blind, placebo-controlled study. J Allergy Clin Immunol 97 (1996) 1207-1213
8. Akdis M., and Akdis C.A. Mechanisms of allergen immunotherapy. J Allergy Clin Immunol 119 (2007) 780-791
9. Jutel M., Watanabe T., Akdis M., Blaser K., and Akdis C.A. Immune regulation by histamine. Curr Opin Immunol 14 (2002) 735-740
10. Simons F.E. Advances in H1-antihistamines. N Engl J Med 351 (2005) 2203-2217
11. Jutel M., Zak-Nejmark T., Wrzyszcz M., and Malolepszy J. Histamine receptor expression on peripheral blood CD4+ lymphocytes is influenced by ultrarush bee venom immunotherapy. Allergy 52 suppl 37 (1997) 88
12. Müller U., Hari Y., and Berchtold E. Premedication with antihistamines may enhance efficacy of specific allergen immunotherapy. J Allergy Clin Immunol 107 (2001) 81-86
13. Mueller H.L. Diagnosis and treatment of insect sensitivity. J Asthma Res 3 (1966) 331-333
14. Müller U. Insect sting allergy: clinical picture, diagnosis and treatment (1990), Gustav Fischer Verlag, New York (NY)
15. Skrbic D., Fischer H., Pitarch D., Jutel M., and Müller U. Ultra-Rush Hyposensibilisierung bei Hymenopterengiftallergie. Allergologie 19 (1996) 123-129
16. Birnbaum J., Charpin D., and Vervloet D. Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols. Clin Exp Allergy 23 (1993) 226-230
17. Müller U., Helbling A., and Berchtold E. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. J Allergy Clin Immunol 89 (1992) 529-535
18. Akdis C.A., Joss A., Akdis M., Faith A., and Blaser K. A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding. FASEB J 14 (2000) 1666-1669
19. Akdis C.A., Blesken T., Akdis M., Wüthrich B., and Blaser K. Role of Interleukin 10 in specific Immunotherapy. J Clin Invest 102 (1998) 98-106
20. Kunzmann S., Mantel P.-Y., Wohlfahrt J., Akdis M., Blaser K., and Schmidt-Weber C. Histamine enhances TGF-beta1-mediated suppression of Th2 responses. FASEB J 17 (2003) 1089-1095
21. Cox L., Li T., Nelson H., and Lockey R. Allergen immunotherapy: a practice parameter second update. J Allergy Clin Immunol 120 (2007) S25-S85
22. Ruëff F., Przybilla B., Müller U.R., and Mosbech H. The sting challenge test in Hymenoptera venom allergy. Allergy 51 (1996) 216-225
23. Müller U., Berchtold E., and Helbling A. Honeybee venom allergy: results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patients. J Allergy Clin Immunol 87 (1991) 702-709
24. Golden D.B.K., Kagey-Sobotka A., and Lichtenstein L. Survey of patients after discontinuing venom immunotherapy. J Allergy Clin Immunol 105 (2000) 385-390
25. Birnbaum J., Charpin D., and Vervloet D. Rapid hymenoptera venom immunotherapy: comparative safety of three protocols. Clin Exp Allergy 23 (1993) 331-333
26. Karppinen A., Kautiainen H., Petman L., Burri P., and Reunala T. Comparison of cetirizine, ebastine and loratadine in the treatment of immediate mosquito-bite allergy. Allergy 57 (2002) 534-537
27. Day J.H., Briscoe M.P., Rafeiro E., and Ratz J.D. Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the environmental exposure unit (EEU). Int J Clin Pract 58 (2004) 109-118
28. Deruaz C., Leimgruber A., Berney M., Pradervand E., and Spertini F. Levocetirizine better protects than desloratadine in a nasal provocation with allergen. J Allergy Clin Immunol 113 (2004) 669-676
29. Thurnheer U., Müller U., Stoller R., Lanner A., and Hoigné R. Venom immunotherapy in Hymenoptera sting allergy. Allergy 38 (1983) 465-475
30. Jutel M., Watanabe T., Klunker S., Akdis M., Thomet O.A.R., Malolepszy J., et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413 (2001) 420-425
31. Mazzoni A., Young H.A., Spitzer J.H., Visintin A., and Segal D.M. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest 108 (2001) 1865-1873
32. Osna N., Elliott K., and Khan M.M. Regulation of interleukin-10 secretion by histamine in TH2 cells and splenocytes. Int Immunopharmacol 1 (2001) 85-96
33. Johansen P., Senti G., Maria Martinez Gomez J., and Kündig T.M. Medication with antihistamines impairs allergen-specific immunotherapy in mice. Clin exp Allergy 38 (2008) 512-519
34. Gelfand E.W., Cui C.H., Katsuyuki T., Kanehiro A., and Joetham A. Fexofenadine modulates T-cell function, preventing allergen-induced airway inflammation and hyperresponsiveness. J Allergy Clin Immunol 110 (2002) 85-95